Clinical Trials for Myelofibrosis
Transform-1
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis. Click here to learn more.
Medical Oncology: 706.353.2990
Radiation Oncology: 706.548.0500
Pharmacy: 706.353.4344
Referrals: 706.353.4346
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis. Click here to learn more.